Inhibition of Platelet-Derived Growth Factor B Signaling Enhances the Efficacy of Anti-Vascular Endothelial Growth Factor Therapy in Multiple Models of Ocular Neovascularization
- 30 June 2006
- journal article
- Published by Elsevier BV in The American Journal of Pathology
- Vol. 168 (6), 2036-2053
- https://doi.org/10.2353/ajpath.2006.050588
Abstract
No abstract availableKeywords
This publication has 50 references indexed in Scilit:
- Stabilization of the retinal vascular network by reciprocal feedback between blood vessels and astrocytesDevelopment, 2005
- Combined inhibition of VEGF‐ and PDGF‐signaling enforces tumor vessel regression by interfering with pericyte‐mediated endothelial cell survival mechanismsThe FASEB Journal, 2003
- Pericyte production of cell-associated VEGF is differentiation-dependent and is associated with endothelial survivalDevelopmental Biology, 2003
- Spatially restricted patterning cues provided by heparin-binding VEGF-A control blood vessel branching morphogenesisGenes & Development, 2002
- The glial precursor proteoglycan, NG2, is expressed on tumour neovasculature by vascular pericytes in human malignant brain tumoursNeuropathology and Applied Neurobiology, 2002
- PRECLINICAL AND PHASE 1A CLINICAL EVALUATION OF AN ANTI-VEGF PEGYLATED APTAMER (EYE001) FOR THE TREATMENT OF EXUDATIVE AGE-RELATED MACULAR DEGENERATIONRetina, 2002
- Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT MethodMethods, 2001
- Inhibition of Choroidal Neovascularization by Intravenous Injection of Adenoviral Vectors Expressing Secretable EndostatinThe American Journal of Pathology, 2001
- Blood vessel maturation: vascular development comes of ageJCI Insight, 1999
- Pericyte Loss and Microaneurysm Formation in PDGF-B-Deficient MiceScience, 1997